Methicillin-resistant Staphylococcus aureus

From WikiMD's Medical Encyclopedia

(Redirected from HA-MRSA)

Methicillin-resistant Staphylococcus aureus (MRSA) Bacteria
Colorized scanning electron micrograph of a human neutrophil ingesting MRSA
Colorized scanning electron micrograph of a human neutrophil ingesting MRSA

Methicillin-resistant Staphylococcus aureus (MRSA) is a type of bacteria that causes an infection resistant to common antibiotics, including methicillin, amoxicillin, and penicillin.<ref>

Methicillin-resistant Staphylococcus aureus (MRSA)(link). Centers for Disease Control and Prevention.


Accessed 2023-05-05.


</ref>

Neutrophil MRSA II

Signs and symptoms[edit]

Most MRSA infections occur on the skin and are mild, presenting as red, swollen, and painful areas, often resembling pimples or spider bites. However, MRSA infections can also be serious or life-threatening, manifesting as pneumonia, bloodstream infections, or bone and joint infections, and can be difficult to treat.<ref>

Methicillin-resistant Staphylococcus aureus (MRSA) Infections(link). Mayo Clinic.


Accessed 2023-05-05.


</ref>

Risk factors[edit]

MRSA infections usually occur in people with weakened immune systems who are in hospitals, nursing homes, or other healthcare centers. They can also occur in healthy people who have skin-to-skin contact with others, such as childcare workers, team athletes, and people who live in crowded conditions. Risk factors include recent hospitalization, invasive procedures, residence in long-term care facilities, and close contact with someone who has MRSA.<ref>

MRSA: Understand your risk and how to prevent infection(link). Mayo Clinic.


Accessed 2023-05-05.


</ref>

Diagnosis[edit]

Diagnosis of MRSA infections typically involves taking a sample from the site of infection and performing a culture and antibiotic susceptibility testing to identify the bacteria and determine its resistance to antibiotics.<ref>

Methicillin-resistant Staphylococcus aureus (MRSA) Infections: Diagnosis & treatment(link). Mayo Clinic.


Accessed 2023-05-05.


</ref>

Prevention[edit]

Prevention strategies for MRSA infections include practicing good hand hygiene, maintaining clean environments, using contact precautions when interacting with infected individuals, and the judicious use of antibiotics to prevent the development of resistance. In healthcare settings, proper infection control measures are essential to minimize the spread of MRSA.<ref>

MRSA: Prevention(link). Centers for Disease Control and Prevention.


Accessed 2023-05-05.


</ref>

Treatment[edit]

Treatment of MRSA infections typically involves the use of antibiotics that are still effective against the resistant bacteria, such as vancomycin, daptomycin, or linezolid. In some cases, surgical intervention may be required to drain abscesses or debride infected tissue. The choice of treatment depends on the severity of the infection and the patient's overall health.<ref>

Methicillin-resistant Staphylococcus aureus (MRSA) Infections: Diagnosis & treatment(link). Mayo Clinic.


Accessed 2023-05-05.


</ref>

Prognosis[edit]

The prognosis of MRSA infections varies depending on the severity of the infection and the patient's overall health. Mild skin infections may resolve with appropriate antibiotic treatment, while more severe infections, such as bloodstream infections or pneumonia, may have a higher risk of complications and mortality.<ref>

MRSA: Prognosis(link). Medscape.


Accessed 2023-05-05.


</ref>

Epidemiology[edit]

The prevalence of MRSA infections varies by region and depends on local antibiotic resistance patterns. In some areas, MRSA accounts for a significant proportion of Staphylococcus aureus infections, while in others, the prevalence may be lower. Both hospital-associated MRSA (HA-MRSA) and community-associated MRSA (CA-MRSA) contribute to the overall burden of disease.<ref>

MRSA: Epidemiology(link). World Health Organization.


Accessed 2023-05-05.


</ref>

References[edit]

This article is a medical stub. You can help WikiMD by expanding it!
PubMed
Wikipedia
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.